This list serves as a guide and is only a summary of the antimicrobials listed on the hospital formulary in this special population. The benefit of treatment and the safety profile of the drug to mother and fetus/baby should be considered and discussed individually with each patient. For more information, please contact a clinical pharmacist or Motherisk at (416)813-6780.

As of June, 2015, the original FDA Pregnancy Category system have been replaced by narrative sections in the product labeling.

Antimicrobial Agents

Antimicrobial Class / Agent Pregnancy Breastfeeding
Aminoglycosides
– Gentamicin
– Tobramycin
– Amikacin
Human data suggest low risk

Monitor drug concentrations
Compatible
Carbapenems
– Ertapenem
– Meropenem
Limited human data suggest low riskProbably compatible
Cephalosporins
– Cefazolin
– Cephalexin
– Cefuroxime
– Ceftriaxone
– Ceftazidime
CompatibleCompatible
ClindamycinCompatibleCompatible
DaptomycinLimited human data; animal studies suggest low riskLimited human data; probably compatible
Fluoroquinolones
– Ciprofloxacin
– Levofloxacin
– Moxifloxacin
Human data suggest low risk

Data on ciprofloxacin did not suggest an increased risk of major malformations

Limited human data for levofloxacin or moxifloxacin
Limited human data, but short-term use is acceptable during breastfeeding

No human data in moxifloxacin
FosfomycinCompatible Limited human data, but probably compatible
LinezolidNo human data; use safer alternatives if possibleNo human data; use safer alternatives if possible
Macrolides
– Erythromycin
– Clarithromycin
– Azithromycin
Erythromycin / Azithromycin: Compatible

Avoid Erythromycin Estolate (increased incidence of maternal hepatotoxicity)

Clarithromycin: limited human data
Erythromycin: Compatible

Azithromycin / Clarithromycin: Limited human data, but probably compatible
MetronidazoleHuman data suggest low riskLimited human data

If use as single-dose therapy (2g orally), delay breastfeeding for 12 to 24 hours
NitrofurantoinAvoid after 37 weeks (risk of hemolytic anemia in newborns)Limited human data, but probably compatible

Potential risk of hemolytic anemia in newborn
Penicillins
– Penicillin G / VK
– Ampicillin
– Amoxicillin ± Clavulanic acid
– Cloxacillin
– Piperacillin Tazobactam
CompatibleConsidered safe
RifampinCompatible

Prophylactic vitamin K1 has been recommended to prevent hemorrhagic disease in the newborn
Compatible
Tetracyclines
– Doxycycline
– Tetracycline
– Minocycline
Avoid in 2nd/3rd TrimestersCompatible

Black discolouration of breast milk has been reported with minocycline (iron chelate of drug)
Trimethoprim [TMP] + sulfamethoxazole [SMX]

( Septra ® )
Avoid in 1st trimester and after 32 weeks’ gestation

If use during 1st trimester is necessary, can give high dose folic acid (4-5mg/day) to minimize neural tube defects
Avoid if infant has G6PD deficiency, premature infants or neonates with hyperbilirubinemia

TMP alone is compatible
VancomycinCompatibleLimited human data, but probably compatible

Anti-Fungal Agents

Anti-Fungal Class / Agent PregnancyBreastfeeding
Amphotericin B
(including liposomal amphotericin)
CompatibleNo human data
AnidulafunginNo controlled studies in pregnancy
No human data
CaspofunginNo human data

Embryotoxic in animal studies; should be avoided in 1st trimester whenever possible
No human data-Probably comptable
FluconazoleMay be teratogenic with continuous daily doses >400mg/day in 1st trimester

Decreased risk in lower doses
Compatible
VoriconazoleNo human data

Animal studies suggest drug is teratogenic and embryotoxic
No human data (potential toxicity)

Antiviral Agents

Antriviral Class / AgentPregnancyBreastfeeding
Acyclovir / valacyclovir
CompatibleCompatible
Ganciclovir / valganciclovir
Limited human data and only should be used when benefit outweighs unknown risk to the fetusNo human data
Oseltamivir
Compatible based on limited human dataCompatible

References

  1. Briggs GG et al. Drugs in Pregnancy and Lactation –9thedition. Philadelphia: Lippincott Williams & Wilkins; 2011.
  2. Various drug monographs. In: DRUGDEX System [database on the Internet]. Colorado:Truven Health Analytics; 2015[cited February 2015]. Available from: www.micromedexsolutions.com. Subscription required to view.
  3. Motherisk. Pregnancy and breastfeeding: the safety of anti-infective agents. In: Cornish B, Walker S AN. Antimicrobial Handbook 2013. Toronto: Sunnybrook Health Sciences Centre; 2013. Pages 73-90.
  4. Einarson A, Ho E, Koren G. Can we use metronidazole in pregnancy? Putting an end to the controversy [Internet]. 2000 [cited February 2015]. Available from: http://www.motherisk.org/prof/updatesDetail.jsp?content_id=328
  5. Zao J, Koren G, Bozzo P. Using nitrofurantoin while breastfeeding a newborn [Internet]. 2014[cited February 2015]. Available from: http://www.motherisk.org/prof/updatesDetail.jsp?content_id=1079
  6. Lee M, Bozzo P, Einarson A, Koren G. Urinary tract infections in pregnancy [Internet]. 2008 [cited February 2015]. Available from: http://www.motherisk.org/prof/updatesDetail.jsp?content_id=882
  7. Product monograph –Invanz. Quebec: Merck Canada Inc; 2014.
  8. Product monograph –Cubicin. Massachusetts: Cubist Pharmaceuticals Inc; 2014.
  9. Bookstaver PB, Bland CM, Stover KR et al. A review of antibiotic use in pregnancy. Pharmacother 2015;35(11):1052-62.